Integrating Tobacco use cessation into HIV Care and Treatment Clinics in Ministry of Health Facilities in Kisumu County, Kenya.

niversity of California San Francisco0 sites580 target enrollmentNovember 18, 2022

ConditionsHIV/AIDS

Overview

No summary available.

Registry

who.int

Start Date

November 18, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity of California San Francisco

•Clinical Component (Randomized Control trial):
•\-age \=18 years
•\-HIV\-seropositive
•\-on or initiating ART
•\-not planning to move or travel within 12 weeks following entry in the study
•\-Tobacco inclusion criteria: current tobacco users, i.e. used tobacco in the past 7 days; for smokers, smoked at least 100 cigarettes in lifetime, and at least 5 cigarettes per day, verified by expired Carbon Monoxide (CO)\= 5\-6 parts per million (ppm).
•\-access to mobile phone for phone contact (and on intensive intervention also for text follow up visit)
•Additional inclusion criteria for intensive intervention only:
•\-able to read or be read for the SMS messages

•Clinical Component:
•\-age \< 18 years
•\-HIV\-seronegative
•\-unable to provide informed consent
•\-unwilling to be contacted by clinic for follow up
•\-Opioid users (who may be receiving Bupropion as part of their treatment)
•Additional exclusion criteria for intensive intervention only:
•\-Myocardial Infarction in the 2 weeks prior to enrolling in the study
•\-Pregnant (as NRT and Bupropion might be contraindicated).
•\-We will also exclude patients for whom Bupropion is contraindicated (e.g. history of seizures, recent use of MAO inhibitors, breastfeeding, and whose ART protocol present, as per prescription guidance, contraindications).